<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02808845</url>
  </required_header>
  <id_info>
    <org_study_id>CIAKI-1</org_study_id>
    <nct_id>NCT02808845</nct_id>
  </id_info>
  <brief_title>Microalbuminuria Predicting CIAKI After CAG</brief_title>
  <acronym>MPCC</acronym>
  <official_title>Pre-existing Microalbuminuria Predicting Contrast-induced Acute Kidney Injury (CIAKI) Following Coronary Angiography (CAG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital with Nanjing Medical University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the association between pre-existing
      microalbuminuria and contrast-induced acute kidney injury (CIAKI) following coronary
      angiography (CAG).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2016</start_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>changes of serum creatinine (SCr, umol/L)</measure>
    <time_frame>24-48 hours after CAG</time_frame>
    <description>the difference of SCr before and after CAG.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of participants with increase in SCr of at least 44.2 umol/L higher than before</measure>
    <time_frame>24-48 hours after CAG</time_frame>
    <description>number of participants with the difference of SCr before and after CAG over 44.2 umol/L.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of participants with increase of SCr over 25% higher than before</measure>
    <time_frame>24-48 hours after CAG</time_frame>
    <description>number of participants with an increase of SCr over 25% higher than before.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes of urine albumin to creatinine ratio (ACR, mg/g)</measure>
    <time_frame>24-48 hours after CAG</time_frame>
    <description>the difference of ACR before and after CAG</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Contrast-induced Acute Kidney Injury</condition>
  <condition>Microalbuminuria</condition>
  <arm_group>
    <arm_group_label>microalbuminuria with eGFR≥60ml/min</arm_group_label>
    <description>microalbuminuria group with estimated glomerular filtration rate (eGFR) ≥60ml/min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal-albuminuria group with eGFR≥60ml/min</arm_group_label>
    <description>normal-albuminuria group with estimated glomerular filtration rate (eGFR) ≥60ml/min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>microalbuminuria group with eGFR&lt;60ml/min</arm_group_label>
    <description>microalbuminuria group with estimated glomerular filtration rate (eGFR) &lt;60ml/min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal-albuminuria group with eGFR&lt;60ml/min</arm_group_label>
    <description>normal-albuminuria group with estimated glomerular filtration rate (eGFR) &lt;60ml/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>microalbuminuria</intervention_name>
    <arm_group_label>microalbuminuria with eGFR≥60ml/min</arm_group_label>
    <arm_group_label>microalbuminuria group with eGFR&lt;60ml/min</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with eGFR ≥ 30 ml/min and without macroalbuminuria (defined as urine albumin to
        creatinine ratio (ACR) &gt;300 mg/g) on admission are prepared to accept scheduled invasive
        coronary angiography during hospitalization.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with eGFR≥30ml/min and without macroalbuminuria undergoing CAG.

        Exclusion Criteria:

          -  Pregnancy

          -  Lactation

          -  Allergic history of contrast media

          -  Having been received contrast media within 7 days

          -  Use of nephrotoxic medications within 7 days

          -  eGFR &lt;30 ml/min, macroalbuminuria (ACR &gt;300 mg/g)

          -  Renal transplantation, emergent coronary angiography

          -  Cardiogenic shock, pulmonary edema

          -  Use of intra-aortic balloon pump (IABP) or mechanical ventilation

          -  Multiple myeloma and other malignant tumor

          -  Life expectancy less than 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhijian Yang, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhijian Yang, Doctor</last_name>
    <phone>+86 13809030208</phone>
    <email>zhijianyangnj@njmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haoyu Meng, Master</last_name>
    <phone>+86 15805167259</phone>
    <email>15805167259@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhijian Yang, Doctor</last_name>
      <phone>+86 13809030208</phone>
      <email>zhijianyangnj@njmu.edu.vn</email>
    </contact>
    <contact_backup>
      <last_name>Haoyu Meng, Master</last_name>
      <phone>+86 15805167259</phone>
      <email>15805167259@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Haoyu Meng, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dingguo Zhang, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yingqiang Du, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.ejradiology.com/article/S0720-048X(16)30085-7/abstract</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://onlinelibrary.wiley.com/doi/10.1002/ccd.21207/abstract;jsessionid=A2FFD546ED3F9BBC54B04B93E8DAE86E.f03t02</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S0735109706018158</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://annals.org/article.aspx?articleid=744251</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://circ.ahajournals.org/content/105/19/2259.long</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://link.springer.com/article/10.1007%2Fs00467-009-1204-z</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://linkinghub.elsevier.com/retrieve/pii/S0272638602093563</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://journals.lww.com/co-nephrolhypertens/pages/articleviewer.aspx?year=2006&amp;issue=11000&amp;article=00014&amp;type=abstract</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://jasn.asnjournals.org/content/17/8/2106.long</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://www.ajconline.org/article/S0002-9149(09)01342-3/abstract</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S0085253815527506</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <link>
    <url>http://www.tandfonline.com/doi/abs/10.3109/0886022X.2013.843400?journalCode=irnf20</url>
    <description>Click here for more information about this study: Microalbuminuria Predicting CIAKI After CAG</description>
  </link>
  <reference>
    <citation>Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv. 2008 Jan 1;71(1):62-72. Review.</citation>
    <PMID>17975790</PMID>
  </reference>
  <reference>
    <citation>Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol. 2006 Sep 5;48(5):924-30. Epub 2006 Aug 17.</citation>
    <PMID>16949481</PMID>
  </reference>
  <reference>
    <citation>Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, Moltrasio M, Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med. 2009 Feb 3;150(3):170-7.</citation>
    <PMID>19189906</PMID>
  </reference>
  <reference>
    <citation>Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002 May 14;105(19):2259-64.</citation>
    <PMID>12010907</PMID>
  </reference>
  <reference>
    <citation>Cronin RE. Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol. 2010 Feb;25(2):191-204. doi: 10.1007/s00467-009-1204-z. Epub 2009 May 15. Review.</citation>
    <PMID>19444480</PMID>
  </reference>
  <reference>
    <citation>National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266.</citation>
    <PMID>11904577</PMID>
  </reference>
  <reference>
    <citation>Lambers Heerspink HJ, Brinkman JW, Bakker SJ, Gansevoort RT, de Zeeuw D. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr Opin Nephrol Hypertens. 2006 Nov;15(6):631-6. Review.</citation>
    <PMID>17053479</PMID>
  </reference>
  <reference>
    <citation>Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol. 2006 Aug;17(8):2106-11. Epub 2006 Jul 6.</citation>
    <PMID>16825333</PMID>
  </reference>
  <reference>
    <citation>Baber U, Mann D, Shimbo D, Woodward M, Olin JW, Muntner P. Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. Am J Cardiol. 2009 Nov 15;104(10):1446-51. doi: 10.1016/j.amjcard.2009.06.068.</citation>
    <PMID>19892066</PMID>
  </reference>
  <reference>
    <citation>Bakris GL, Ruilope L, Locatelli F, Ptaszynska A, Pieske B, de Champlain J, Weber MA, Raz I. Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int. 2007 Oct;72(7):879-85. Epub 2007 Aug 1.</citation>
    <PMID>17667984</PMID>
  </reference>
  <reference>
    <citation>Sany D, Refaat H, Elshahawy Y, Mohab A, Ezzat H. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients. Ren Fail. 2014 Mar;36(2):191-7. doi: 10.3109/0886022X.2013.843400. Epub 2013 Oct 21.</citation>
    <PMID>24138570</PMID>
  </reference>
  <results_reference>
    <citation>Meng H, Wu P, Zhao Y, Xu Z, Wang ZM, Li C, Wang L, Yang Z. Microalbuminuria in patients with preserved renal function as a risk factor for contrast-Induced acute kidney injury following invasive coronary angiography. Eur J Radiol. 2016 Jun;85(6):1063-7. doi: 10.1016/j.ejrad.2016.03.010. Epub 2016 Mar 16.</citation>
    <PMID>27161053</PMID>
  </results_reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2016</study_first_submitted>
  <study_first_submitted_qc>June 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2016</study_first_posted>
  <last_update_submitted>June 21, 2016</last_update_submitted>
  <last_update_submitted_qc>June 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>coronary angiography</keyword>
  <keyword>contrast-induced acute kidney injury</keyword>
  <keyword>microalbuminuria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Albuminuria</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

